bcl-2 expression in endometrial hyperplasia and carcinoma

被引:33
|
作者
Niemann, TH
Trgovac, TL
McGaughy, VR
Vaccarello, L
机构
[1] ARTHUR G JAMES CANC HOSP,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,MED CTR,DIV GYNECOL ONCOL,COLUMBUS,OH 43210
关键词
D O I
10.1006/gyno.1996.0329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The bcl-2 gene codes for a protein which functions to inhibit apoptotic cell death. bcl-2 overexpression was originally described in follicular lymphoma, but more recently bcl-2 expression has been observed in a variety of other human neoplasms. In this study we used immunohistochemistry to examine bcl-2 protein expression in endometrial hyperplasia and carcinoma. bcl-2 protein was observed in 4/4 cases of complex hyperplasia, 1/4 cases of complex atypical hyperplasia, and 10/29 cases of carcinoma. The staining observed in the cases of complex atypical hyperplasia and carcinoma was focal and less intense than the reactivity of normal proliferative endometrium. We conclude that bcl-2 protein is seldom overexpressed in complex atypical hyperplasia or carcinoma of the endometrium. Rather, in many cases of endometrial carcinoma bcl-2 expression appears to be decreased. (C) 1996 Academic Press, Inc.
引用
收藏
页码:318 / 322
页数:5
相关论文
共 50 条
  • [1] BCL-2 EXPRESSION AND THE DEVELOPMENT OF ENDOMETRIAL CARCINOMA
    CHHIENG, DC
    ROSS, JS
    AMBROS, RA
    LABORATORY INVESTIGATION, 1995, 72 (01) : A87 - A87
  • [2] bcl-2 expression and the development of endometrial carcinoma
    Chhieng, DC
    Ross, JS
    Ambros, RA
    MODERN PATHOLOGY, 1996, 9 (04) : 402 - 406
  • [3] Expression and correlation of Bcl-2, ER and PR in endometrial hyperplasia
    Wu, Jiping
    Xue, Yanjun
    Lin, Lihong
    Ma, Yuan
    Ma, Yanli
    Cui, Shuo
    Wang, Yifei
    Zhang, Xia
    Ma, Li
    MINERVA MEDICA, 2023, 114 (02) : 269 - 271
  • [4] NUCLEAR AND CYTOPLASMIC BCL-2 EXPRESSION IN ENDOMETRIAL HYPERPLASIA AND ADENOCARCINOMA
    CHAN, WK
    MOLE, MM
    LEVISON, DA
    BALL, RY
    LU, QL
    PATEL, K
    HANBY, AM
    JOURNAL OF PATHOLOGY, 1995, 177 (03): : 241 - &
  • [5] Expression of Bcl-2 in Imprint Smears of Endometrial Carcinoma
    Mitropoulou Kosmas Konstantinos
    Stamoulas Georgia
    Klapsinou Marios
    Marouga Eirini
    Cytology and Genetics, 2020, 54 : 372 - 378
  • [6] Expression of Bcl-2 in Imprint Smears of Endometrial Carcinoma
    Konstantinos, Kosmas
    Georgia, Mitropoulou
    Marios, Stamoulas
    Eirini, Klapsinou
    Anna, Marouga
    CYTOLOGY AND GENETICS, 2020, 54 (04) : 372 - 378
  • [7] BCL-2 expression and prognosis of patients with endometrial carcinoma
    Sakuragi, N
    Ohkouchi, T
    Hareyama, H
    Ikeda, K
    Watari, H
    Fujimoto, T
    Kuwabara, M
    Yamamoto, R
    Sagawa, T
    Fujino, T
    Fujimoto, S
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (02) : 153 - 158
  • [8] Aberrant bcl-2 deficiency in endometrial hyperplasia
    Jafari-Nejad, Kambin
    Orell, Svante
    Henshaw, Richard
    Tokushige, Natsuko
    Russell, Peter
    PATHOLOGY, 2011, 43 (04) : 378 - 380
  • [9] Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study
    Samani, Simin Mirakhor
    Bojnordi, Tahmineh Ezazi
    Zarghampour, Manijeh
    Merat, Sobhan
    Fouladi, Daniel F.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 38 (07) : 999 - 1004
  • [10] Cell proliferation, programmed cell death and Bcl-2 expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma.
    Mora, LB
    Nicosia, SV
    Cantor, A
    Diez, JI
    LABORATORY INVESTIGATION, 1997, 76 (01) : 611 - 611